Idiopathic intracranial hypertension (IIH): shunting

Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .

Idiopathic intracranial hypertension (IIH): shunting. Reduced visual acuity at onset, Progressive visual loss. Fully referenced neurology checklist.

Indications

  • Reduced visual acuity at onset
  • Progressive visual loss
  • Severe (high-grade) papilloedema
  • Malignant IIH: rapid visual decline 
  • Atrophic papilloedema
  • Recent weight gain
  • Hypertension
  • Subretinal haemorrhage

Benefits

Locked: subscribe to see this section.

Protocol

Locked: subscribe to see this section.

Complications

Locked: subscribe to see this section.

References

  1. Friedman DI, Jacobson DM. Idiopathic intracranial hypertension. J Neuro Ophthalmol 2004; 24:138-145.
  2. Wall M, Falardeau J, Fletcher WA, et al; NORDIC Idiopathic Intracranial Hypertension Study Group. Risk factors for poor visual outcome in patients with idiopathic intracranial hypertension. Neurology 2015; 85:799-805. 
  3. Sinclair AJ, Kuruvath S, Sen D, Nightingale PG, Burdon MA, Flint G. Is cerebrospinal fluid shunting in idiopathic intracranial hypertension worthwhile? A 10-year review. Cephalalgia 2011; 31:1627-1633.
  4. Mollan SP, Davies B, Silver NC, et al. Idiopathic intracranial hypertension: consensus guidelines on management. JNNP 2018; 89:1088-1100.
  5. Brune AJ, Girgla T, Trobe JD. Complications of ventriculoperitoneal shunt for idiopathic intracranial hypertension: a single-institution study of 32 patients. J Neuroophthalmol 2021; 41:224-232.

Related checklists

Loading...